首页> 外文期刊>European journal of gynaecological oncology >MRI in the synchronic chemoradiotherapy of cervical squamous cell carcinoma
【24h】

MRI in the synchronic chemoradiotherapy of cervical squamous cell carcinoma

机译:MRI在宫颈鳞癌同步放化疗中的应用

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: This study aimed to explore the predictive value of the apparent diffusion coefficient (ADC) of diffusion weighted imaging (DWI) in evaluating the therapeutic effects of synchronic chemoradiotherapy of cervical squamous cell carcinoma by using the functional imaging of 1.5T MR. Materials and Methods: Fifty patients with cervical squamous cell carcinoma receiving synchronic chemoradiotherapy in the present hospital from October 2010 to February 2014 were enrolled in this study. MRI examination was performed on each patient before and after chemoradiotherapy. Eleven patients received an additional MRI examination when the in vitro cumulative radiation dose reached 36 Gy. The mean tumor ADC values of DWI sequence were measured before, under, and after chemoradiotherapy. At the end of the treatment, patients were divided into complete remission (CR) and partial remission (PR) groups on the basis of the residual tumors. Then the tumor ADC values and their changes before and after the treatment were analyzed using independent sample t-test. Results: At the end of the treatment, 32 patients achieved CR and 18 patients achieved PR. The tumor ADC values increased gradually with the treatment, showing significant difference between before, under, and after the treatment (p < 0.01). The mean tumor ADC values were remarkably higher in CR group than in PR group (p < 0.001). Conclusion: The ADC values of MR functional imaging DWI can reflect the hydrone diffusion movement of tumor after the treatment, so that it is able to identify CR and PR in the patients, providing a new way and method for evaluating the therapeutic effects of cervical squamous cell carcinoma.
机译:目的:探讨1.5T MR功能成像在弥散加权成像(DWI)的表观扩散系数(ADC)对宫颈鳞状细胞癌同步放化疗疗效评价中的预测价值。材料与方法:选择2010年10月至2014年2月在本院接受同步放化疗的50例宫颈鳞状细胞癌患者作为研究对象。在放化疗前后对每位患者进行MRI检查。当体外累积放射剂量达到36 Gy时,有11名患者接受了额外的MRI检查。在放化疗之前,期间和之后测量DWI序列的平均肿瘤ADC值。在治疗结束时,根据残留肿瘤将患者分为完全缓解(CR)组和部分缓解(PR)组。然后使用独立的样本t检验分析治疗前后的肿瘤ADC值及其变化。结果:在治疗结束时,32例获得CR,18例获得PR。肿瘤ADC值随治疗逐渐增加,显示治疗前,治疗中和治疗后的显着差异(p <0.01)。 CR组的平均肿瘤ADC值显着高于PR组(p <0.001)。结论:MR功能成像DWI的ADC值可以反映治疗后肿瘤的水肿扩散运动,从而能够鉴别出患者的CR和PR,为评估宫颈鳞状细胞癌的疗效提供了新的途径和方法细胞癌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号